•  
  •  
 

Joint Force Quarterly

Abstract

The limited repertoire of the biomanufacturing industry in the 20th century pales in comparison to today’s biotechnology industry, in which advancements in the fields of synthetic biology, artificial intelligence, and robotics have resulted in the rapid expansion of small-scale production capabilities and the development of corresponding high-throughput experimentation platforms that accommodate both generation and downstream processing of biologically derived materials and are poised to revolutionize the way civilian and military sectors produce materials.

Share

COinS